TABLE 2

Kinetic parameters for the penetration across the monolayers of polarized cell lines expressing mouse Mdr1a and their corresponding control cells

Permeabilities across LLC-PK1/L-mdr1a were determined by the slops from 1 to 3 h in the transcellular transport. Transport of apical-to-basal (A to B) and basal-to-apical (B to A) direction represent the mean ± S.E.M. (n = 3).

CompoundTransport
LLC–PK1L–mdr1a
A to BB to AA to BB to A
μl/h/well
Antipyrine31.2 ± 1.929.6 ± 3.028.7 ± 3.325.6 ± 1.3
Benzylpenicillin5.2 ± 0.73.7 ± 0.37.5 ± 1.44.7 ± 0.3
Buspirone40.7 ± 3.139.9 ± 1.038.6 ± 0.638.4 ± 1.4
Caffeine32.1 ± 1.234.5 ± 2.229.7 ± 1.735.4 ± 2.7
Carbamazepine41.0 ± 0.946.5 ± 1.240.6 ± 2.645.2 ± 1.9
Cephalexin4.0 ± 0.23.7 ± 0.44.8 ± 0.33.7 ± 0.1
Citalopram32.0 ± 5.335.5 ± 5.425.9 ± 3.339.2 ± 4.1
Cimetidine3.6 ± 0.020.2 ± 1.23.2 ± 0.815.0 ± 2.6
Daidzein16.5 ± 0.739.1 ± 0.917.3 ± 1.341.0 ± 1.2
Dantrolene22.5 ± 1.338.6 ± 1.224.3 ± 0.439.2 ± 3.3
Diazepam44.4 ± 1.843.7 ± 1.946.5 ± 1.442.2 ± 1.1
Flavopiridol26.6 ± 1.139.6 ± 1.79.6 ± 2.2***67.3 ± 9.8**
Fleroxacin5.0 ± 0.26.1 ± 0.35.4 ± 0.27.5 ± 0.6
Genistein17.8 ± 1.033.1 ± 4.114.7 ± 1.628.1 ± 0.8
Loperamide22.1 ± 0.615.0 ± 1.212.9 ± 0.7**54.7 ± 2.3***
Midazolam41.4 ± 3.142.2 ± 1.238.1 ± 0.544.5 ± 3.0
Pefloxacin5.4 ± 1.78.5 ± 0.15.1 ± 1.512.3 ± 0.7**
Phenytoin31.0 ± 2.237.7 ± 1.529.6 ± 1.637.1 ± 1.7
Quinidine22.3 ± 0.822.9 ± 1.16.6 ± 0.6***42.2 ± 2.2**
Risperidone41.8 ± 0.145.9 ± 1.521.3 ± 4.9*63.0 ± 2.6**
Sertraline2.7 ± 0.21.9 ± 0.22.8 ± 0.22.4 ± 0.3
Sulpiride1.9 ± 0.22.4 ± 0.12.0 ± 0.72.7 ± 0.3
Thiopental37.1 ± 1.436.4 ± 1.739.6 ± 2.037.7 ± 1.1
Verapamil24.9 ± 0.523.4 ± 1.315.4 ± 1.1**49.0 ± 1.9***
Zolpidem42.4 ± 1.841.6 ± 1.940.3 ± 0.745.8 ± 4.6
  • Statistically significant differences in the permeability between transporter-expressing cells and the corresponding control cells: *, P < 0.05; **, P < 0.01; and ***, P < 0.001.